AD	Alzheimer’s disease
ADNI	Alzheimer’s Disease Neuroimaging Initiative
AIBL	Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing
Aβ	Beta-amyloid
BBB	Blood-brain barrier
CL	Centiloid
CN	Cognitively normal
CNS	Central nervous system
CR3	Complement receptor 3
CR4	Complement receptor 4
CSF	Cerebrospinal fluid
EM	Episodic memory
GWAS	Genome-wide association studies
MCI	Mild cognitive impairment
MFI	Mean fluorescence intensity
MRI	Magnetic resonance imaging
NF-κB	Nuclear factor kappa light chain enhancer of activated B cells
NK cell	Natural killer cell
P2X7	P2X purinoceptor 7
PACC	Preclinical Alzheimer’s Cognitive Composite
PET	Positron emission tomography
P-tau181P	Tau phosphorylated at threonine 181
SNP	Single nucleotide polymorphism
SP1	Specificity protein 1
T-tau	Total tau